Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

VIRTUAL REALITY TRAINING AFTER THORACIC SURGERY (VRTS)

7. Juli 2026 aktualisiert von: Orcin Telli Atalay, Pamukkale University

Effects of Exercise Training With Virtual Reality After Thoracic Surgery

This study aims to investigate the effects of virtual reality-based exercise training after thoracic surgery. Participants undergoing lung resection surgery will be assigned to either a virtual reality exercise training group or a control group receiving standard care. Physical function, pulmonary function, exercise capacity, dyspnea, anxiety, depression, and quality of life will be evaluated before and after the intervention. The findings may help determine whether virtual reality-assisted exercise training improves postoperative recovery in patients undergoing thoracic surgery.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Studientyp

Interventionell

Einschreibung (Tatsächlich)

30

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

Age between 25 and 70 years Stable symptoms and no other disease affecting pulmonary function (e.g., scoliosis or ankylosing spondylitis) Good cooperation and ability to walk independently Patients who underwent thoracic surgery FEV1 > 2 L for pneumonectomy, > 1 L for lobectomy, and > 0.6 L for segmentectomy Maximum oxygen consumption (VO₂max) > 15-20 mL/kg/min Cycle ergometer performance > 83 W No severe visual impairment Approved for participation in exercise training by the operating physician Hodkinson Mental Test score > 6 Willingness to participate and provision of informed consent -

Exclusion Criteria:

Contraindications to pulmonary rehabilitation or physiotherapy, including unstable cardiovascular disease, severe pulmonary hypertension, severe uncorrectable hypoxemia, exercise-induced desaturation, rib fractures, subcutaneous emphysema, advanced osteoporosis, or thrombocytopenia Orthopedic or neurological disorders that may impair independent ambulation, exertional dyspnea, or exertional vertigo Requirement for repeat thoracic surgery due to previous thoracic surgical history Inability to establish verbal and/or auditory communication and cooperation Inability to cooperate due to psychological and/or perceptual impairments Withdrawal Criteria Development of unexpected chest pain during the study Occurrence of syncope or nausea during testing procedures Participants may withdraw from the study at any time without providing a reason Study Completion / Termination Criterion Achievement of the planned sample size

-

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Conventional Pulmonary Rehabilitation Group
Participants received conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Sonstiges: Conventional Pulmonary Rehabilitation and Cycle Ergometer Training
Participants received conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Verfahren: thoracic surgery
Participants underwent thoracic surgery (lobectomy, segmentectomy, pneumonectomy, or wedge resection) according to the clinical indication before receiving the assigned rehabilitation intervention.
Experimental: Virtual Reality Exercise Training Group
Participants received conventional pulmonary rehabilitation, cycle ergometer training, and virtual reality-based exercise training after thoracic surgery.
Sonstiges: Conventional Pulmonary Rehabilitation and Cycle Ergometer Training
Participants received conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Verfahren: thoracic surgery
Participants underwent thoracic surgery (lobectomy, segmentectomy, pneumonectomy, or wedge resection) according to the clinical indication before receiving the assigned rehabilitation intervention.
Verhalten: Virtual Reality Exercise Training
Participants received virtual reality-based exercise training in addition to conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
FEV1
Zeitfenster: From baseline to 2 weeks after hospital discharge
Forced expiratory volume in one second (FEV1) measured by spirometry.
From baseline to 2 weeks after hospital discharge
FVC
Zeitfenster: From baseline to 2 weeks after hospital discharge.
Forced vital capacity (FVC) measured by spirometry.
From baseline to 2 weeks after hospital discharge.
FEF25-75
Zeitfenster: From baseline to 2 weeks after hospital discharge.
Forced expiratory flow between 25% and 75% of forced vital capacity measured by spirometry.
From baseline to 2 weeks after hospital discharge.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Pain Intensity
Zeitfenster: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Pain intensity was assessed using the Visual Analog Scale (VAS).Pain intensity was assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Exercise Capacity
Zeitfenster: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Exercise capacity was assessed using the 1-minute sit-to-stand test.Exercise capacity was assessed using the 1-minute sit-to-stand test (1-min STS). The outcome was recorded as the number of completed sit-to-stand repetitions in one minute. Higher values indicate better exercise capacity.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Anxiety and Depression
Zeitfenster: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Anxiety and depression were assessed using the Hospital Anxiety and Depression. Anxiety was assessed using the Hospital Anxiety and Depression Scale - Anxiety subscale (HADS-A). Scores range from 0 to 21, with higher scores indicating greater anxiety symptoms. Depression was assessed using the Hospital Anxiety and Depression Scale - Depression subscale (HADS-D). Scores range from 0 to 21, with higher scores indicating greater depression symptoms.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Dyspnea
Zeitfenster: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Dyspnea was assessed using the Modified Borg Dyspnea Scale. Dyspnea was assessed using the Modified Borg Dyspnea Scale. Scores range from 0 to 10, where 0 indicates no dyspnea and 10 indicates maximal dyspnea. Higher scores indicate greater dyspnea severity.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Oxygen Saturation
Zeitfenster: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Peripheral oxygen saturation was measured before, immediately after, and 3 minutes after the 1-minute sit-to-stand test.Peripheral oxygen saturation (SpO₂) was measured using a pulse oximeter before, immediately after, and 3 minutes after the 1-minute sit-to-stand test. Oxygen saturation was recorded as a percentage (%), with higher values indicating better oxygenation.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Length of Hospital Stay
Zeitfenster: From the day of surgery until hospital discharge (typically within 7 days after surgery).
Length of hospital stay was recorded as the total number of days from surgery until hospital discharge. Shorter hospital stay indicates a better outcome.
From the day of surgery until hospital discharge (typically within 7 days after surgery).
Patient satisfaction
Zeitfenster: Hospital discharge (up to 7 days after surgery)
Patient satisfaction was assessed using a short patient satisfaction questionnaire.Patient satisfaction was assessed using the Short Patient Satisfaction Questionnaire (SPSQ/HMKDF), which consists of 7 items rated on a 5-point Likert scale. Total scores range from 7 to 35, with higher scores indicating greater patient satisfaction.
Hospital discharge (up to 7 days after surgery)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Pamukkale University

Ermittler

  • Hauptermittler: Orçin T ATALAY, PhD, Pamukkale University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

24. Oktober 2024

Primärer Abschluss (Tatsächlich)

27. Februar 2026

Studienabschluss (Tatsächlich)

27. Februar 2026

Studienanmeldedaten

Zuerst eingereicht

26. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

7. Juli 2026

Zuerst gepostet (Tatsächlich)

14. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

14. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

7. Juli 2026

Zuletzt verifiziert

1. Juli 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • E-76351742-050.04-572695

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data will not be shared because the study was conducted as part of an academic thesis project and the informed consent process did not include provisions for public sharing of de-identified participant-level data.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Bewegungstraining

Suchen Sie nach ähnlichen Studien

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

CROs by country

CROs in Ukraine

Bedingungen

Seltene Krankheiten

Drogeninterventionen

Nahrungsergänzungsmittel

Sponsor / Mitarbeiter

Standorte

3
Abonnieren